Literature DB >> 19100866

Modulation of the effects of tropomyosin on actin and myosin conformational changes by troponin and Ca2+.

Yurii S Borovikov1, Olga E Karpicheva, Stanislava V Avrova, Charles S Redwood.   

Abstract

The molecular mechanisms by which troponin (TN)-tropomyosin (TM) regulates the myosin ATPase cycle were investigated using fluorescent probes specifically bound to Cys36 of TM, Cys707 of myosin subfragment-1, and Cys374 of actin incorporated into ghost muscle fibers. Intermediate states of actomyosin were simulated by using nucleotides and non-hydrolysable ATP analogs. Multistep changes in mobility and spatial arrangement of SH1 helix of myosin motor domain and actin subdomain-1 during the ATPase cycle were observed. Each intermediate state of actomyosin induced a definite conformational state and specific position of TM strands on the surface of thin filament. TM increased the amplitude of myosin SH1 helix and actin subdomain-1 movements at transition from weak- to strong-binding states shifting to the center of thin filament at strong-binding and to the periphery of thin filament at weak-binding states. TN modulated those movements in a capital ES, Cyrillicsmall a, Cyrillic(2+)-dependent manner. At high-Ca(2+), TN enhanced the effect of TM on SH1 helix and subdomain-1 movements by transferring TM further to the center of thin filament at strong-binding states. In contrast, at low-Ca(2+), TN inhibited the effect of TM movements, "freezing" actin structure in "OFF" state and TM in the position typical for weak-binding states, resulting in disturbing the interplay of actin and myosin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100866     DOI: 10.1016/j.bbapap.2008.11.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Calcium-dependent interaction sites of tropomyosin on reconstituted muscle thin filaments with bound Myosin heads as studied by site-directed spin-labeling.

Authors:  Keisuke Ueda; Chieko Kimura-Sakiyama; Tomoki Aihara; Masao Miki; Toshiaki Arata
Journal:  Biophys J       Date:  2013-11-19       Impact factor: 4.033

2.  Interaction between troponin and myosin enhances contractile activity of myosin in cardiac muscle.

Authors:  Brenda Schoffstall; Vincent A LaBarbera; Nicolas M Brunet; Belinda J Gavino; Lauren Herring; Sara Heshmati; Brittany H Kraft; Vanessa Inchausti; Nancy L Meyer; Danamarie Moonoo; Aya K Takeda; Prescott Bryant Chase
Journal:  DNA Cell Biol       Date:  2011-03-27       Impact factor: 3.311

3.  Structural and protein interaction effects of hypertrophic and dilated cardiomyopathic mutations in alpha-tropomyosin.

Authors:  Audrey N Chang; Norma J Greenfield; Abhishek Singh; James D Potter; Jose R Pinto
Journal:  Front Physiol       Date:  2014-12-02       Impact factor: 4.566

4.  Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca2+ Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation.

Authors:  Yurii S Borovikov; Armen O Simonyan; Stanislava V Avrova; Vladimir V Sirenko; Charles S Redwood; Olga E Karpicheva
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

5.  Looking for Targets to Restore the Contractile Function in Congenital Myopathy Caused by Gln147Pro Tropomyosin.

Authors:  Olga E Karpicheva; Armen O Simonyan; Nikita A Rysev; Charles S Redwood; Yurii S Borovikov
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

6.  Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7.

Authors:  Yurii S Borovikov; Daria D Andreeva; Stanislava V Avrova; Vladimir V Sirenko; Armen O Simonyan; Charles S Redwood; Olga E Karpicheva
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

7.  Molecular mechanisms of dysfunction of muscle fibres associated with Glu139 deletion in TPM2 gene.

Authors:  Yurii S Borovikov; Nikita A Rysev; Olga E Karpicheva; Vladimir V Sirenko; Stanislava V Avrova; Adam Piers; Charles S Redwood
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.